Analyst Research
| Report Title | Price |
|---|---|
|
Trading Report for (CVS). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Wright Reports
|
$495.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
CVS Caremark Corporation Issues FY 2012 Revenue Guidance-Conference Call
CVS Caremark Corporation announced that for fiscal 2012, it expects to add a total of $12.6 billion in net new revenues with a 98% retention rate.
Latest Developments for CVS Caremark Corp
- Cvs Caremark Corp Raises Low End Of Prior FY 2013 EPS Guidance To A Range In Line With Analysts' Estimates; Issues Q2 2013 EPS Guidance In Line With Analysts' Estimates
- Cvs Caremark Corp Buys Drogaria Onofre-Reuters
- Cvs Caremark Corp Raises FY 2013 EPS Guidance
- Cvs Caremark Corp Issues FY 2013 EPS Guidance In Line With Analysts' Estimates-Conference Call
- Share this
- Link this
- Digg this
Follow Reuters